Harpoon Therapeutics, Inc(NASDAQ:HARP) 
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cel...
Website: http://www.harpoontx.com
Founded: 2015
Full Time Employees: 77
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-09-12
P
O 7.37
H 7.50
L 6.81
C 6.81
V 35,776
10EMA 6.81
20EMA 6.81
60EMA 6.81
120EMA 6.81
250EMA 6.81